Mirae Asset Global Etfs Holdings Ltd. Compass Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 45,556 shares of CMPX stock, worth $86,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,556Holding current value
$86,556% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CMPX
# of Institutions
85Shares Held
92.7MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$42.5 Million0.54% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$21.1 Million0.02% of portfolio
-
Blackstone Inc New York, NY7.69MShares$14.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$12.6 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.51MShares$10.5 Million0.17% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $192M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...